Kirn David 4
4 · 4D Molecular Therapeutics, Inc. · Filed Dec 13, 2023
Insider Transaction Report
Form 4
Kirn David
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-12-11+590,000→ 590,000 totalExercise: $14.42Exp: 2033-12-10→ Common Stock (590,000 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of December 11, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.